2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Who cites it

249 citing papers in PubMed, 8 syntheses or guidelines pooled it.

1. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).European heart journal · 2016 · on this map
   Guideline
2. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Journal of the American College of Cardiology · 2014 · on this map
   Guideline
3. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation · 2014
   Guideline
4. Screening for peripheral arterial disease.The Cochrane database of systematic reviews · 2014
   Pooled it
5. Frequency of Testing for Dyslipidemia: An Evidence-Based Analysis.Ontario health technology assessment series · 2014
   Pooled it
6. Statins for the primary prevention of cardiovascular disease.The Cochrane database of systematic reviews · 2013 · on this map
   Pooled it
7. How diet modification challenges are magnified in vulnerable or marginalized people with diabetes and heart disease: a systematic review and qualitative meta-synthesis.Ontario health technology assessment series · 2013
   Pooled it
8. Managing cardiometabolic risk in primary care: summary of the 2011 consensus statement.Canadian family physician Medecin de famille canadien · 2012
   Guideline
9. Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial.The British journal of surgery · 2022
   Trial
10. Concordance of care processes between medical records and patient self-administered questionnaires.BMC family practice · 2019
    Trial
11. Assessing family history of chronic disease in primary care: Prevalence, documentation, and appropriate screening.Canadian family physician Medecin de famille canadien · 2017
    Trial
12. Comprehensive Analysis of Established Dyslipidemia-Associated Loci in the Diabetes Prevention Program.Circulation. Cardiovascular genetics · 2016
    Trial
13. Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes.Lipids in health and disease · 2016
    Trial
14. Variations in HDL-carried miR-223 and miR-135a concentrations after consumption of dietary trans fat are associated with changes in blood lipid and inflammatory markers in healthy men - an exploratory study.Epigenetics · 2016
    Trial
15. Sex differences in the impact of the Mediterranean diet on systemic inflammation.Nutrition journal · 2015
    Trial
16. Consumer attitudes and understanding of cholesterol-lowering claims on food: randomize mock-package experiments with plant sterol and oat fibre claims.European journal of clinical nutrition · 2014
    Trial
17. Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada.American heart journal · 2014 · on this map
    Trial
18. Effect of an intervention to improve the cardiovascular health of family members of patients with coronary artery disease: a randomized trial.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2014
    Trial
19. Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial.Lancet (London, England) · 2014
    Trial
20. Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.Vascular health and risk management · 2014
    Trial

189 more citing papers are in PubMed but not listed here.

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

23 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as